5 Common Weight-Loss Drug Mistakes Patients Make—Doctor’s Warning

Weight-loss medications known as GLP-1 drugs, including semaglutide and tirzepatide, have surged in popularity for their effectiveness in managing diabetes and aiding weight loss. However, a growing body of evidence suggests these medications may offer benefits beyond metabolic health—including improvements in cardiovascular and kidney function. Despite their potential, experts warn that improper use can undermine results or even pose health risks. Dr. Meena T. Malhotra, a functional medicine physician and weight-loss specialist based near Chicago, has identified five critical mistakes patients often make when taking these drugs, based on her clinical observations.

GLP-1 Drugs: More Than Just Weight Loss

GLP-1 medications, originally developed to treat type 2 diabetes, work by mimicking the glucagon-like peptide-1 hormone, which regulates appetite, slows gastric emptying, and improves insulin sensitivity. While their weight-loss effects have captured public attention, research increasingly highlights broader health benefits. Dr. Malhotra noted that in her practice, diabetic patients on GLP-1 drugs showed marked improvements in areas beyond blood sugar control and weight management.

“We observed that this sick population was doing better than the diabetics who were on other diabetes medicines. We realized there was more to the drug than just sugar control and weight loss.”

Dr. Meena T. Malhotra, functional medicine physician and weight-loss specialist

Among the improvements she documented were enhanced brain health, memory function, cardiovascular performance, circulation, and liver and kidney function. These findings align with emerging research suggesting GLP-1 drugs may reduce the risk of major adverse cardiovascular events and slow the progression of chronic kidney disease in certain patient populations.

Five Common Mistakes Undermining Treatment

Despite their potential, GLP-1 medications are not a one-size-fits-all solution. Dr. Malhotra emphasized that improper use can lead to suboptimal outcomes or new health complications. Below are the five critical mistakes she frequently encounters in her practice:

• Prioritizing medication over lifestyle changes. Many patients begin GLP-1 therapy without first adopting sustainable dietary and exercise habits. Dr. Malhotra stressed that these drugs are most effective when used as part of a comprehensive lifestyle plan, not as a standalone solution. “Anyone considering GLP-1s should first focus on adopting a healthy lifestyle,” she advised, noting that this perspective is widely shared among endocrinologists and obesity medicine specialists.
• Insufficient protein intake. One of the most common errors is reducing calorie consumption without ensuring adequate protein. This can lead to muscle loss rather than fat loss, compromising metabolic health. “If you are decreasing the calories but not fixing the nutritional foundation, you will lose lean mass,” Dr. Malhotra warned.
• Skipping baseline and follow-up testing. Some patients forgo initial lab work or regular check-ups due to perceived cost or convenience. However, baseline testing—including kidney function, glucose levels (when indicated), and medication reconciliation—is critical to identify potential contraindications or drug interactions. Dr. Malhotra recommended structured follow-up appointments at 4–12 weeks after starting treatment and again at 6–12 months to monitor progress and adjust other medications, such as insulin or sulfonylureas, as needed.
• Unrealistic expectations and premature discontinuation. Social media and marketing often portray GLP-1 drugs as quick fixes, leading some patients to expect rapid, dramatic results. In reality, weight loss tends to be gradual and varies by individual. While appetite suppression may occur early, sustained weight loss typically requires months of consistent use. Dr. Malhotra advised treating GLP-1 therapy as part of a long-term plan that includes dietary modifications and physical activity.
• Ignoring side effects or contraindications. While many patients tolerate GLP-1 drugs well, some experience gastrointestinal side effects, such as nausea or constipation. Others may have underlying conditions that make these medications unsuitable. Dr. Malhotra cautioned against self-adjusting doses or continuing treatment without medical supervision, as this can exacerbate risks or reduce efficacy.

Who Benefits Most from GLP-1 Therapy?

While GLP-1 drugs are not appropriate for everyone, certain groups may experience particularly significant benefits. Dr. Malhotra highlighted that patients with type 2 diabetes, obesity, or metabolic syndrome often see the most pronounced improvements in metabolic and cardiovascular health. For these individuals, the drugs may help reduce the risk of complications such as heart disease, stroke, and kidney failure.

However, she also noted that some patients without diabetes or obesity may still benefit from lower, “microdosing” regimens. This approach requires careful monitoring to balance efficacy and safety, particularly in individuals with a history of gastrointestinal disorders or other medical conditions.

Balancing Benefits and Risks

The growing evidence supporting GLP-1 drugs’ broader health benefits has led to increased interest in their off-label use. However, experts caution that these medications are not without risks. Common side effects include nausea, vomiting, diarrhea, and constipation, which may subside over time but can be severe in some cases. More serious, though rare, risks include pancreatitis, gallbladder disease, and low blood sugar (hypoglycemia), particularly when combined with other diabetes medications.

Dr. Malhotra emphasized the importance of individualized care, stating that GLP-1 therapy should be tailored to each patient’s unique health profile. “We realized there was more to the drug than just sugar control and weight loss,” she said, underscoring the need for a holistic approach that addresses nutrition, physical activity, and regular medical oversight.

What Patients Should Consider Before Starting Treatment

For those considering GLP-1 medications, Dr. Malhotra offered several key recommendations:

• Consult a healthcare provider. Before starting treatment, patients should undergo a thorough medical evaluation to assess suitability, potential risks, and necessary baseline testing.
• Adopt a balanced diet. Focus on nutrient-dense foods, adequate protein intake, and hydration to support weight loss and overall health. Avoid extreme calorie restriction, which can lead to muscle loss and nutritional deficiencies.
• Incorporate physical activity. Regular exercise enhances the metabolic benefits of GLP-1 drugs and helps preserve lean muscle mass during weight loss.
• Set realistic expectations. Understand that weight loss with GLP-1 therapy is typically gradual and may require long-term commitment. Celebrate non-scale victories, such as improved energy levels, better blood sugar control, or enhanced mobility.
• Prioritize follow-up care. Regular check-ins with a healthcare provider are essential to monitor progress, adjust dosages, and address any side effects or complications.

The Future of GLP-1 Research

As research into GLP-1 drugs continues, scientists are exploring their potential applications in other areas of health. Preliminary studies suggest these medications may have neuroprotective effects, potentially benefiting conditions such as Alzheimer’s disease and Parkinson’s disease. Ongoing trials are investigating their role in reducing inflammation, improving liver function, and even treating addiction.

However, experts caution that much of this research is still in its early stages. While the findings are promising, more rigorous studies are needed to confirm these benefits and establish long-term safety profiles. In the meantime, healthcare providers emphasize the importance of using GLP-1 drugs as part of a broader, evidence-based treatment plan rather than relying on them as a standalone solution.

Conclusion

GLP-1 medications represent a significant advancement in the treatment of diabetes and obesity, with emerging evidence suggesting they may offer additional health benefits. However, their effectiveness and safety depend heavily on proper use. By avoiding common mistakes—such as neglecting lifestyle changes, skipping follow-up care, or setting unrealistic expectations—patients can maximize the benefits of these drugs while minimizing risks.

As Dr. Malhotra’s observations highlight, GLP-1 therapy is most successful when integrated into a comprehensive approach that includes nutrition, exercise, and regular medical supervision. For those considering these medications, consulting a healthcare provider and committing to a long-term plan are critical steps toward achieving sustainable health improvements.